Synaptic Ventures

Synaptic Ventures is an early-stage venture capital firm specializing in investing in psychedelic medicine. The company focuses on investing in early-stage private companies with the potential to go public, primarily in North American markets. The portfolio includes producers of psychedelic compounds, both natural and synthetic, clinical trial sponsors, and companies developing innovative products in the space. Synaptic Ventures takes an active role in helping its portfolio companies navigate the capital markets in North America. With extensive experience in taking companies public in North America, on the NASDAQ, TSX, and other Canadian exchanges, the firm's team offers valuable expertise to its portfolio companies. Despite the missing information about its founding date, industries, headquarters, last investment, and last investment investors, Synaptic Ventures' commitment to supporting companies in the psychedelic medicine space sets it apart in the venture capital landscape.